Re: Belgium WORLD Conf Sept 99,agenda

[Guest guest]

http://www.cfs-clinic.com/program.htm

<A HREF= " http://www.cfs-clinic.com/program.htm " >Program CFS World

Congress</A>

Second World Congress on C.F.S.

Chronic Fatigue Syndrome and Related Disorders:

Towards effective diagnosis and treatment in the 21st century

September 9-10-11-12, 1999 Brussels, Belgium

------------------------------------------------------------------------------

--

Site Map | Organization | General Conditions | Individual Registration Form |

Hotelrequirements | Social Events | Email

Program

Sept.9 Gulf War Syndrome

Sept.10 Session I Biochemistry of fatigue and pain

Session II Epidemiology

Session III Immunology

Session IV Microbiology

Sept.11 Session V Physiology

Session VI Diagnosis

Session VII Clinical observations

Session VIII Treatment

Sept.10-11 Poster Session

Sept.12 Satellite Meeting 1 and 2

------------------------------------------------------------------------------

--

Calendar of sessions

Thursday September 9th, 1999

Venue : Atomium

13:00-19:00 REGISTRATION

14:00-18:00 Natelson B.H.

PTSD, chemical exposures and abnormal changes in cardiovascular functioning

in Gulf Veter ans (GVs) with Chronic Fatigue

Levine P.H.

Evidence for an environmental-related Gulf War Syndrome by factor analysis

Hooper M.

Towards a fuller understanding of Gulf War Illness/Syndrome (GWI/S)

Nicolson B.

Identification and treatment of chronic infections in Gulf war Illness

patients

18:00-20:00 Opening ceremony : Cocktail reception in the Atomium

------------------------------------------------------------------------------

--

Friday September 10th, 1999

Venue : Palace 7 - Heysel

08:00-17:00 REGISTRATION

08:00-17:00 POSTERS

Session I : Biochemistry of fatigue and pain

08:30-09:30 McGregor N.R.

The biochemistry of Chronic Pain and Fatigue

09:30-09:50 Butt H.L.

The association of staphylococcal membrane-damaging toxin and Chronic

Fatigue/Pain

09:50-10:10 R.H.

The development of laboratory-based tests in Chronic Pain and Fatigue :

Essential fatty acids and cholesterol

10:10-10:30 Kuratsune H.

Brain regions responsible for fatigue sense ? Reduced acetylcarnitine uptake

with pet into Brodmann's area 9 and 24 in patients with Chronic Fatigue

Syndrome

10:30-10:50 T.K.

Biochemical anomalies associated with visual processing disability (scotopic

vision) in Chronic Fatigue Syndrome

10:50-11:05 BREAK

Session II : Epidemiology

11:05-11:45 Goldberg J.

?

11:45-11:00 Levine P.H.

Chronic Fatigue Syndrome and cancer : is there a relationship ?

11:00-12:15 Olin R.

FMS-, CFS- and TMS-prevalences in a Swedish country (Wärmland).

questionnaire- and oral examination-based study.

12:15-12:30 Weaver M.G.

Risk of fatigue and Chronic Fatigue Syndrome in association with hepatitis C

viral infection in patients with bleeding disorders

12:30-13:30 LUNCH

Session III : Immunology

13:30-14:00 Klimas N.

Overview of immunological abnormalities in CFS

14:00-14:30 Brostoff

Allergy in CFS

14:30-14:45 Lambrecht L.

The Chronic Fatigue Syndrome : clinical, immunological and neuro- imaging

correlations in 500 patients

14:45-15:00 Kuma

Immune abnormalities in 16 ME/CFS patients

15:00-15:15 Regland B.

Nickel allergy in patients with fibromyalgia and Chronic Fatigue Syndrome

15:15-15:30 Stejskal V.

Metal-specific lymphocytes : risk factors in CFS and other related Diseases

15:30-15:45 Stejskal V.

Mercury and nickel allergy : Risk factors in fatigue and autoimmunity

15:45-16:15 BREAK

Session IV : Microbiology

16:15-16:30 De Meirleir K.

Opportunistic infections in CFS

16:30-16:45 Butt H.

The development of laboratory-based tests in Chronic Fatigue and Pain : Fecal

microbiology and biochemistry

16:45-17:00 R.H.

The development of laboratory-based tests in Chronic Pain and Fatigue :

Muscle catabolism and coagulase negative staphylococci which produce

membrane-damaging toxins

17:00-17:15 Jadin C.

Common Clinical and Biological windows on CFS and Rickettsiae Disease

17:15-17:30 Nix W.A.

Neuromuscular transmission defect in patients with Chronic Fatigue Syndrome

19:00 CONGRESS DINER

Saturday September 11th 1999

Venue : Palace 7 - Heysel

08:00-17:00 REGISTRATION

08:00-17:00 POSTERS

Session V : Rnase L in CFS

08:30-09:00 Lebleu B.

The interferron-activated 2-5A/Rnase L pathway : an overview

09:00-09:20 Lebleu B.

A 37 Kda 2-5A binding protein as a potential Biochemical marker for Chronic

Fatigue Syndrome

09:20-9:50 Suhadolnik R.J.

Diagnosis of Chronic Fatigue Syndrome (CFS) : Determination of a low

molecular weight 37 Kda 2-5A dependent Rnase L in peripheral blood

mononuclear cell extracts

9:50-10:10 De Meirleir K.

The low molecular Rnase L pathway abnormalities in CFS : The clinical use in

clinical practice

10:10-10:30 BREAK

Session VI : Diagnosis

10:30-10:45 Bottero P.

Rickettsiae and chlamydiae in patient psychopathology 98 Chronic Fatigue

Syndrome (CFS) and 79 other : A diagnostic and a therapeutic report.

10:45-11:00 Gaab J.

Hypothalamic-pituitary-adrenal axis reactivity and alterations of

glucocorticoid sensitivity under psychological and physiological stress in

Chronic Fatigue Syndrome and health

11:00-11:15 Hyde B.

The technological investigation of ME/CFS patients

11:15-11:30 T.K.

The development of laboratory-based tests in Chronic Fatigue Pain and Fatigue

: Investigation of erythrocyte oxidative damage in CFS

11:30-11:45 Moorkens Greta

Characterization of pituitary function in 73 patients with Chronic Fatigue

Syndrome

11:45-12:00 Bell S.

Method of long term follow-up for Chronic fatigue Syndrome patients

12:00-13:00 LUNCH

Session VII : Clinical Observations

13:00-13:15 Bastien S.

Motor abnormalities associated with neuropsychologically compromised Chronic

Fatigue Syndrome patients

13:15-13:30 Cabane J.

The biorhythm of fatigue in Chronic Fatigue Syndrome

13:30-13:45 Deluca J.

Clarifying the nature of memory impairment in chronic fatigue syndrome :

acquisition versus retrieval deficit

13:45-14:00 Hardt J.

Low quality of life in patients with CFS : similar pattern in United States,

United Kingdom and Germany

14:00-14:15 Hyde B.

The clinical investigation of acute onset of ME/CFS and MS following

recombinant hepatitis B immunization 14:15-14:30 Nix W. Altered perception of

muscle force in patients with Chronic Fatigue Syndrome

14:30-14:45 Posner N.

Pattern of functional impairment in CFS

14:45-15:00 Rowe K.

Does the symptom complex of chronic fatigue syndrome occur in Adolescents

15:00-15:15 De Becker P.

Measuring physical disability in patients with chronic fatigue syndrome using

exercise testing

15:15-15:30 Scroop G.C.

Normal exercise capacity in chronic fatigue syndrome

15:30-16:00 BREAK

Session VIII : Treatment

16:00-16:15 Bottero P.

Clinical treatment for rickettsiae and chlamydiae

16:15-16:30 Hyde B.

A seven month blinded treatment trial with isoprinosine

16:30-16:45 Klimas N.K.

Alteration of type 1/type 2 cytokine pattern following adoptive immunotherapy

of patients with chronic fatigue syndrome (CFS) using autologous EX vivo

expanded lymph node cells

16:45-17:00 Strayer D.

Optimalization of the dosing schedule (twice VS. thrice weekly) of ampligen

in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)

17:00-17:15 Strayer D./ W.A.

Pharmacoeconomic analysis of Ampligen intervention in CFS/ME

17:15-17:30 De Meirleir K.

The 509B Ampligen trial in Belgium

19:00 CONCERT

------------------------------------------------------------------------------

--

Posters (Sept.10 - 11)

Barker L.

The outcome of an out-patient group program for chronic fatigue syndrome

Bervoets K.

Prevalence of bronchial hyperresponsiveness (BHR) in CFS patients

Brouns E.

Correlation between cellular immunity and bronchial hyperreactivity in CFS

patients

De Becker P.

Comparison between Chronic Fatigue Syndrome and Chronic Fatigue patients

De Becker P.

Mode of onset in CFS patients

De Becker P.

Natural history : A 6 month clinical Follow-up

De Becker P.

Symptomatology in a large cohort of Belgian CFS-patients

De Becker P.

Blood transfusion and Chronic Fatigue Syndrome

Dierckx

?

Fitzgibbon E.J.

Quality of life and work in persons with chronic fatigue syndrome

Habets L.

LMW Rnase L testing in CF/CFIDS patients with different disease patterns

Höck A.D.

Divalent cations, their hormones, psyche and soma. 4 case reports.

D.

Study on multiple chemical sensitivity (MCS) patients

D.

CO- Trimoxazole/Trimethoprim - ME/CFS/CFIDS/FMS cases

Lambrecht L.

Chronic Fatigue Syndrome : Psychomotor & Autonomic Dysfunction

Meghan S.

Health care workers, predominant gender, female at highest risk Turning the

spotlight on the endocrine system

Pizzigallo E.

Oxidative status and muscle damage in CFS patients : results

Reynders Masha

Cytokine levels in CFS patients

Rowe K.S.

Symptom patterns in CFS in adolescents

Vallings R.

Pregnancy experiences of patients with chronic fatigue syndrome

Van Moffaert M.

Gender and CFS : Mid-life and elderly women's vulnerability

Zachrisson O.C.G.

Irritable bowel syndrome in patients with fibromyalgia and chronic fatigue

syndrome

Zainal N.Z.

Family history study of chronic fatigue syndrome

------------------------------------------------------------------------------

--

Sunday September 12th,1999

Venue:

P.M. : A.Z.-VUB Laarbeeklaan 101, Jette

Auditorium Kiekens

A.M. : Hoger Instituut Verpleegkunde

Brussel, Campus Jette

10:00-12:00 Satellite meeting one :

Viki C.

What is in a name- Atomium disorder instead of CFS

Satellite meeting two :

Dan

Disability evaluation in CFS

12:00-13:00 BREAK (LUNCH ???)

13:00-16:00 CFS-Patients meeting Summary of the Congress

16:00-17:00 CFS Patients meet the expert

Site Map | Organization | General Conditions | Individual Registration Form |

Hotelrequirements | Social Events | Email